YU30303A - Molecular inclusion complexes of allicin with cyclodextrines and derivatives thereof, method for preparation, and pharmaceutical application thereof - Google Patents

Molecular inclusion complexes of allicin with cyclodextrines and derivatives thereof, method for preparation, and pharmaceutical application thereof

Info

Publication number
YU30303A
YU30303A YU30303A YUP30303A YU30303A YU 30303 A YU30303 A YU 30303A YU 30303 A YU30303 A YU 30303A YU P30303 A YUP30303 A YU P30303A YU 30303 A YU30303 A YU 30303A
Authority
YU
Yugoslavia
Prior art keywords
allicin
derivatives
cyclodextrines
molecular inclusion
synthesis
Prior art date
Application number
YU30303A
Other languages
Serbo-Croatian (sh)
Inventor
Vesna NIKOLIĆ
Mihajlo STANKOVIĆ
Agneš Kapor
Jakov Stamenković
Ljubiša NIKOLIĆ
Dragan Cvetković
Original Assignee
Vesna NIKOLIĆ
Mihajlo STANKOVIĆ
Agneš Kapor
Jakov Stamenković
Ljubiša NIKOLIĆ
Dragan Cvetković
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vesna NIKOLIĆ, Mihajlo STANKOVIĆ, Agneš Kapor, Jakov Stamenković, Ljubiša NIKOLIĆ, Dragan Cvetković filed Critical Vesna NIKOLIĆ
Priority to YU30303A priority Critical patent/YU30303A/en
Publication of YU30303A publication Critical patent/YU30303A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Herewith explained procedure is in the field of synthesis of organic compounds and relates to new products, molecular inclusion complexes of allicin with cyclodextirnes or derivatives thereof, procedure for obtaining and application thereof in the form of pharmaceutical formulations in pharmaceutical industry. Synthesis of the complex sets out in a synthesis of allicin, oxidation of allyldisulphide in acidic hydrogen peroxide and purification thereof in extraction thereof with ether, where purity of obtained allicin is 70 - 80 %. Molecular inclusion complex of allicin with cyclodextrines or derivatives thereof are synthesized from allicin and cyclodextrines or derivatives thereof in a technique of solid complexes formation by kneading method. Molecular inclusion complexes are a matter of great interest for preparation of pharmacologically active formulations wherein a uniform content of active substance exists. Hereby prepared products provide reduced vaporization and degradation of active component and significantly correct an unpleasant smell and irritative taste of allicin.
YU30303A 2003-04-18 2003-04-18 Molecular inclusion complexes of allicin with cyclodextrines and derivatives thereof, method for preparation, and pharmaceutical application thereof YU30303A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU30303A YU30303A (en) 2003-04-18 2003-04-18 Molecular inclusion complexes of allicin with cyclodextrines and derivatives thereof, method for preparation, and pharmaceutical application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU30303A YU30303A (en) 2003-04-18 2003-04-18 Molecular inclusion complexes of allicin with cyclodextrines and derivatives thereof, method for preparation, and pharmaceutical application thereof

Publications (1)

Publication Number Publication Date
YU30303A true YU30303A (en) 2006-05-25

Family

ID=37616541

Family Applications (1)

Application Number Title Priority Date Filing Date
YU30303A YU30303A (en) 2003-04-18 2003-04-18 Molecular inclusion complexes of allicin with cyclodextrines and derivatives thereof, method for preparation, and pharmaceutical application thereof

Country Status (1)

Country Link
YU (1) YU30303A (en)

Similar Documents

Publication Publication Date Title
HRP20070198A2 (en) Compositions of estrogen-cyclodextrin complexes
MA27867A1 (en) NOVEL 2H-PYRIDAZINE-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES AND PROCESS FOR PREPARING THE ACTIVE INGREDIENT
UA103758C2 (en) Insulin-oligomer conjugates, formulations and uses thereof
MX2010003588A (en) Process for the manufacture of a pharmaceutical product.
GEP20053492B (en) 5-Chloro-3-(4-Methanesulfonylphenyl)-6'-Methyl- [2,3']Bipyridinyl in Pure Crystalline Form and Process for Production Thereof
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
MXPA02009643A (en) Shortened synthesis of 3,3-diarylpropylamine derivatives.
ATE452120T1 (en) FATTY ACID BENZENEDIOL DERIVATIVES AND PRODUCTION AND USE PROCESSES THEREOF
PL1793862T3 (en) A process for the preparation of a piroxicam: beta-cyclodextrin inclusion compound
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
WO2003063824A3 (en) Pharmaceutical composition
AU2001286003A1 (en) Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
WO2013032558A4 (en) Products for anti-inflammation support
MY134691A (en) A PROCESS FOR THE PREPARATION OF PIROXICAM: ß-CYCLODEXTRIN INCLUSION COMPOUNDS
WO2008024277A3 (en) Kw-3902 conjugates that do not cross the blood-brain barrier
YU30303A (en) Molecular inclusion complexes of allicin with cyclodextrines and derivatives thereof, method for preparation, and pharmaceutical application thereof
WO2002085921A3 (en) Simple method for the synthesis of boswellic acids and derivatives thereof
MX2007003468A (en) Medicinal aerosol formulations and methods of synthesizing ingredients therefor.
NZ596464A (en) Anticancer compound and pharmaceutical composition containing the same
MX2009008068A (en) Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same.
WO2010086129A8 (en) Inclusion complex comprising cinacalcet and cyclodextrin
YU32903A (en) Canal inclusion complex of allicin with carbamide, method for preparation and pharmaceutical applications thereof
WO2001000652A3 (en) 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
AU2001266019A1 (en) 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives